25 XP   0   0   10

Harbin Gloria Pharmaceuticals
Buy, Hold or Sell?

Let's analyse Gloria together

PenkeI guess you are interested in Harbin Gloria Pharmaceuticals. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Harbin Gloria Pharmaceuticals. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Harbin Gloria Pharmaceuticals

I send you an email if I find something interesting about Harbin Gloria Pharmaceuticals.

Quick analysis of Gloria (30 sec.)










What can you expect buying and holding a share of Gloria? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥0.75
Expected worth in 1 year
¥0.27
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
¥-0.36
Return On Investment
-17.4%

For what price can you sell your share?

Current Price per Share
¥2.09
Expected price per share
¥1.67 - ¥2.18
How sure are you?
50%

1. Valuation of Gloria (5 min.)




Live pricePrice per Share (EOD)

¥2.09

Intrinsic Value Per Share

¥-1.34 - ¥2.03

Total Value Per Share

¥-0.59 - ¥2.78

2. Growth of Gloria (5 min.)




Is Gloria growing?

Current yearPrevious yearGrowGrow %
How rich?$235m$273m-$38m-16.2%

How much money is Gloria making?

Current yearPrevious yearGrowGrow %
Making money-$40.2m$6.2m-$46.4m-115.5%
Net Profit Margin-9.4%1.4%--

How much money comes from the company's main activities?

3. Financial Health of Gloria (5 min.)




What can you expect buying and holding a share of Gloria? (5 min.)

Welcome investor! Gloria's management wants to use your money to grow the business. In return you get a share of Gloria.

What can you expect buying and holding a share of Gloria?

First you should know what it really means to hold a share of Gloria. And how you can make/lose money.

Speculation

The Price per Share of Gloria is ¥2.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gloria.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gloria, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥0.75. Based on the TTM, the Book Value Change Per Share is ¥-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.03 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gloria.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.02-0.8%-0.02-0.8%0.000.1%-0.03-1.4%0.000.0%
Usd Book Value Change Per Share-0.02-0.8%-0.02-0.8%0.000.1%-0.03-1.5%0.00-0.2%
Usd Dividend Per Share0.000.2%0.000.2%0.000.2%0.010.4%0.010.4%
Usd Total Gains Per Share-0.01-0.6%-0.01-0.6%0.010.3%-0.02-1.1%0.010.3%
Usd Price Per Share0.35-0.35-0.40-0.40-1.41-
Price to Earnings Ratio-19.80--19.80-146.69-38.59-79.46-
Price-to-Total Gains Ratio-27.91--27.91-56.51-12.11-64.62-
Price to Book Ratio3.39-3.39-3.34-3.25-8.29-
Price-to-Total Gains Ratio-27.91--27.91-56.51-12.11-64.62-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.28842
Number of shares3467
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.02-0.03
Usd Total Gains Per Share-0.01-0.02
Gains per Quarter (3467 shares)-43.54-80.75
Gains per Year (3467 shares)-174.15-322.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
158-232-184107-430-333
2116-464-358213-859-656
3174-696-532320-1289-979
4232-928-706427-1719-1302
5290-1161-880534-2149-1625
6348-1393-1054640-2578-1948
7406-1625-1228747-3008-2271
8464-1857-1402854-3438-2594
9522-2089-1576960-3867-2917
10580-2321-17501067-4297-3240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%11.02.00.084.6%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%11.02.00.084.6%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%11.02.00.084.6%

Fundamentals of Gloria

About Harbin Gloria Pharmaceuticals

Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-14 16:19:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Harbin Gloria Pharmaceuticals.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Gloria earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Gloria to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -9.4% means that ¥-0.09 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is -9.4%. The company is making a loss. -1
  • The TTM is -9.4%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-9.4%0.0%
TTM-9.4%YOY1.4%-10.8%
TTM-9.4%5Y-9.0%-0.3%
5Y-9.0%10Y5.5%-14.5%
1.1.2. Return on Assets

Shows how efficient Gloria is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gloria to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.2% Return on Assets means that Gloria generated ¥-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is -7.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.2%TTM-7.2%0.0%
TTM-7.2%YOY1.0%-8.1%
TTM-7.2%5Y-7.5%+0.4%
5Y-7.5%10Y-0.1%-7.4%
1.1.3. Return on Equity

Shows how efficient Gloria is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gloria to the Drug Manufacturers - Specialty & Generic industry mean.
  • -17.9% Return on Equity means Gloria generated ¥-0.18 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is -17.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.9%TTM-17.9%0.0%
TTM-17.9%YOY2.4%-20.2%
TTM-17.9%5Y-33.2%+15.3%
5Y-33.2%10Y-9.7%-23.5%

1.2. Operating Efficiency of Harbin Gloria Pharmaceuticals.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gloria is operating .

  • Measures how much profit Gloria makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gloria to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY3.7%-3.7%
TTM-5Y3.3%-3.3%
5Y3.3%10Y10.3%-7.1%
1.2.2. Operating Ratio

Measures how efficient Gloria is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.19 means that the operating costs are ¥1.19 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is 1.188. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.188. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.188TTM1.1880.000
TTM1.188YOY1.208-0.020
TTM1.1885Y1.196-0.008
5Y1.19610Y0.975+0.221

1.3. Liquidity of Harbin Gloria Pharmaceuticals.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gloria is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.78 means the company has ¥0.78 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is 0.777. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.777. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.777TTM0.7770.000
TTM0.777YOY0.822-0.044
TTM0.7775Y0.735+0.042
5Y0.73510Y0.538+0.197
1.3.2. Quick Ratio

Measures if Gloria is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gloria to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.12 means the company can pay off ¥0.12 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is 0.119. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.119. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.119TTM0.1190.000
TTM0.119YOY0.119+0.001
TTM0.1195Y0.148-0.028
5Y0.14810Y0.227-0.079

1.4. Solvency of Harbin Gloria Pharmaceuticals.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gloria assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gloria to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.58 means that Gloria assets are financed with 58.2% credit (debt) and the remaining percentage (100% - 58.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is 0.582. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.582. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.582TTM0.5820.000
TTM0.582YOY0.579+0.003
TTM0.5825Y0.604-0.022
5Y0.60410Y0.519+0.085
1.4.2. Debt to Equity Ratio

Measures if Gloria is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gloria to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 145.3% means that company has ¥1.45 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harbin Gloria Pharmaceuticals:

  • The MRQ is 1.453. The company is able to pay all its debts with equity. +1
  • The TTM is 1.453. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.453TTM1.4530.000
TTM1.453YOY1.434+0.019
TTM1.4535Y1.726-0.273
5Y1.72610Y1.317+0.409

2. Market Valuation of Harbin Gloria Pharmaceuticals

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Gloria generates.

  • Above 15 is considered overpriced but always compare Gloria to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -19.80 means the investor is paying ¥-19.80 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harbin Gloria Pharmaceuticals:

  • The EOD is -16.289. Based on the earnings, the company is expensive. -2
  • The MRQ is -19.796. Based on the earnings, the company is expensive. -2
  • The TTM is -19.796. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.289MRQ-19.796+3.507
MRQ-19.796TTM-19.7960.000
TTM-19.796YOY146.689-166.485
TTM-19.7965Y38.594-58.390
5Y38.59410Y79.458-40.864
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harbin Gloria Pharmaceuticals:

  • The EOD is 20.758. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 25.228. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 25.228. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.758MRQ25.228-4.469
MRQ25.228TTM25.2280.000
TTM25.228YOY27.568-2.340
TTM25.2285Y-32.819+58.047
5Y-32.81910Y43.408-76.227
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gloria is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Harbin Gloria Pharmaceuticals:

  • The EOD is 2.786. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.385. Based on the equity, the company is fair priced.
  • The TTM is 3.385. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.786MRQ3.385-0.600
MRQ3.385TTM3.3850.000
TTM3.385YOY3.339+0.047
TTM3.3855Y3.252+0.133
5Y3.25210Y8.293-5.040
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Harbin Gloria Pharmaceuticals compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.121-0.1210%0.020-699%-0.225+85%-0.029-76%
Book Value Per Share--0.7500.7500%0.872-14%1.022-27%1.275-41%
Current Ratio--0.7770.7770%0.822-5%0.735+6%0.538+44%
Debt To Asset Ratio--0.5820.5820%0.579+1%0.604-4%0.519+12%
Debt To Equity Ratio--1.4531.4530%1.434+1%1.726-16%1.317+10%
Dividend Per Share--0.0300.0300%0.031-3%0.056-46%0.068-55%
Eps---0.128-0.1280%0.020-747%-0.210+64%-0.001-99%
Free Cash Flow Per Share--0.1010.1010%0.106-5%0.181-44%0.200-50%
Free Cash Flow To Equity Per Share--0.1010.1010%0.265-62%-0.025+125%0.224-55%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.033--------
Intrinsic Value_10Y_min---1.336--------
Intrinsic Value_1Y_max--0.201--------
Intrinsic Value_1Y_min--0.014--------
Intrinsic Value_3Y_max--0.606--------
Intrinsic Value_3Y_min---0.085--------
Intrinsic Value_5Y_max--1.013--------
Intrinsic Value_5Y_min---0.324--------
Market Cap4745366067.200-22%5767095603.2005767095603.2000%6607184332.800-13%6575397191.680-12%23156909600.819-75%
Net Profit Margin---0.094-0.0940%0.014-755%-0.090-4%0.055-272%
Operating Margin----0%0.037-100%0.033-100%0.103-100%
Operating Ratio--1.1881.1880%1.208-2%1.196-1%0.975+22%
Pb Ratio2.786-22%3.3853.3850%3.339+1%3.252+4%8.293-59%
Pe Ratio-16.289+18%-19.796-19.7960%146.689-113%38.594-151%79.458-125%
Price Per Share2.090-22%2.5402.5400%2.910-13%2.896-12%10.199-75%
Price To Free Cash Flow Ratio20.758-22%25.22825.2280%27.568-8%-32.819+230%43.408-42%
Price To Total Gains Ratio-22.968+18%-27.913-27.9130%56.513-149%12.109-331%64.620-143%
Quick Ratio--0.1190.1190%0.119+0%0.148-19%0.227-47%
Return On Assets---0.072-0.0720%0.010-845%-0.075+5%-0.001-98%
Return On Equity---0.179-0.1790%0.024-851%-0.332+86%-0.097-46%
Total Gains Per Share---0.091-0.0910%0.051-277%-0.169+85%0.039-336%
Usd Book Value--235088688.001235088688.0010%273090092.645-14%320096425.522-27%399513052.450-41%
Usd Book Value Change Per Share---0.017-0.0170%0.003-699%-0.031+85%-0.004-76%
Usd Book Value Per Share--0.1040.1040%0.120-14%0.141-27%0.176-41%
Usd Dividend Per Share--0.0040.0040%0.004-3%0.008-46%0.009-55%
Usd Eps---0.018-0.0180%0.003-747%-0.029+64%0.000-99%
Usd Free Cash Flow--31547130.20931547130.2090%33074266.401-5%56793407.631-44%62538957.719-50%
Usd Free Cash Flow Per Share--0.0140.0140%0.015-5%0.025-44%0.028-50%
Usd Free Cash Flow To Equity Per Share--0.0140.0140%0.037-62%-0.003+125%0.031-55%
Usd Market Cap654860517.274-22%795859193.242795859193.2420%911791437.926-13%907404812.452-12%3195653524.913-75%
Usd Price Per Share0.288-22%0.3510.3510%0.402-13%0.400-12%1.407-75%
Usd Profit---40203378.943-40203378.9430%6215799.447-747%-65746438.294+64%-282591.737-99%
Usd Revenue--428896432.163428896432.1630%434053015.130-1%547678001.583-22%438104263.372-2%
Usd Total Gains Per Share---0.013-0.0130%0.007-277%-0.023+85%0.005-336%
 EOD+4 -4MRQTTM+0 -0YOY+5 -305Y+17 -1810Y+5 -30

3.2. Fundamental Score

Let's check the fundamental score of Harbin Gloria Pharmaceuticals based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-16.289
Price to Book Ratio (EOD)Between0-12.786
Net Profit Margin (MRQ)Greater than0-0.094
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.119
Current Ratio (MRQ)Greater than10.777
Debt to Asset Ratio (MRQ)Less than10.582
Debt to Equity Ratio (MRQ)Less than11.453
Return on Equity (MRQ)Greater than0.15-0.179
Return on Assets (MRQ)Greater than0.05-0.072
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Harbin Gloria Pharmaceuticals based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.368
Ma 20Greater thanMa 502.076
Ma 50Greater thanMa 1002.092
Ma 100Greater thanMa 2002.255
OpenGreater thanClose2.050
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,074,186
Total Liabilities2,370,645
Total Stockholder Equity1,631,238
 As reported
Total Liabilities 2,370,645
Total Stockholder Equity+ 1,631,238
Total Assets = 4,074,186

Assets

Total Assets4,074,186
Total Current Assets1,816,198
Long-term Assets2,257,988
Total Current Assets
Cash And Cash Equivalents 1,237,743
Short-term Investments 50,564
Net Receivables 228,592
Inventory 214,136
Other Current Assets 10,919
Total Current Assets  (as reported)1,816,198
Total Current Assets  (calculated)1,741,955
+/- 74,243
Long-term Assets
Property Plant Equipment 1,119,434
Goodwill 369,032
Intangible Assets 225,692
Long-term Assets Other 12,954
Long-term Assets  (as reported)2,257,988
Long-term Assets  (calculated)1,727,113
+/- 530,875

Liabilities & Shareholders' Equity

Total Current Liabilities2,336,310
Long-term Liabilities34,335
Total Stockholder Equity1,631,238
Total Current Liabilities
Short Long Term Debt 1,454,973
Accounts payable 75,481
Other Current Liabilities 11,343
Total Current Liabilities  (as reported)2,336,310
Total Current Liabilities  (calculated)1,541,797
+/- 794,513
Long-term Liabilities
Long-term Liabilities  (as reported)34,335
Long-term Liabilities  (calculated)0
+/- 34,335
Total Stockholder Equity
Total Stockholder Equity (as reported)1,631,238
Total Stockholder Equity (calculated)0
+/- 1,631,238
Other
Capital Stock2,198,123
Common Stock Shares Outstanding 2,198,123
Net Debt 217,231
Net Invested Capital 3,086,211
Net Working Capital -520,112
Property Plant and Equipment Gross 2,082,473



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
2,194,470
2,312,254
2,564,606
2,942,981
4,922,350
8,318,360
8,666,544
9,064,144
9,477,173
6,407,580
4,516,311
4,695,144
4,074,186
4,074,1864,695,1444,516,3116,407,5809,477,1739,064,1448,666,5448,318,3604,922,3502,942,9812,564,6062,312,2542,194,470
   > Total Current Assets 
0
0
0
0
0
2,063,514
2,012,389
2,029,789
2,816,073
3,203,079
1,785,106
2,200,424
1,816,198
1,816,1982,200,4241,785,1063,203,0792,816,0732,029,7892,012,3892,063,51400000
       Cash And Cash Equivalents 
1,538,323
1,453,523
1,262,704
829,923
1,071,154
1,193,363
1,201,834
961,794
1,305,013
1,311,775
895,445
1,495,713
1,237,743
1,237,7431,495,713895,4451,311,7751,305,013961,7941,201,8341,193,3631,071,154829,9231,262,7041,453,5231,538,323
       Short-term Investments 
0
0
80,000
270,000
0
0
0
0
0
0
0
0
50,564
50,56400000000270,00080,00000
       Net Receivables 
95,320
93,314
173,016
189,149
174,458
423,080
406,010
530,765
1,002,406
572,867
332,394
318,448
228,592
228,592318,448332,394572,8671,002,406530,765406,010423,080174,458189,149173,01693,31495,320
       Inventory 
53,265
72,473
67,538
120,580
163,445
277,421
271,256
469,313
446,333
455,631
370,956
352,092
214,136
214,136352,092370,956455,631446,333469,313271,256277,421163,445120,58067,53872,47353,265
   > Long-term Assets 
0
0
0
0
0
0
6,654,156
7,034,356
6,661,100
3,204,501
2,731,204
2,494,719
2,257,988
2,257,9882,494,7192,731,2043,204,5016,661,1007,034,3566,654,156000000
       Property Plant Equipment 
266,930
416,254
560,948
668,685
831,401
1,644,949
1,814,943
1,778,417
1,720,441
1,501,458
1,339,717
1,235,273
1,119,434
1,119,4341,235,2731,339,7171,501,4581,720,4411,778,4171,814,9431,644,949831,401668,685560,948416,254266,930
       Goodwill 
0
0
0
0
1,848,291
3,623,157
3,683,213
3,641,240
3,360,234
411,160
411,160
411,160
369,032
369,032411,160411,160411,1603,360,2343,641,2403,683,2133,623,1571,848,2910000
       Long Term Investments 
0
0
0
0
0
154,679
480,368
517,827
766,544
0
0
0
0
0000766,544517,827480,368154,67900000
       Intangible Assets 
12,146
10,294
7,923
273,878
2,218,340
431,244
462,292
706,341
618,179
435,164
355,147
296,702
225,692
225,692296,702355,147435,164618,179706,341462,292431,2442,218,340273,8787,92310,29412,146
       Long-term Assets Other 
0
0
0
0
0
0
155,408
283,589
22,946
18,805
16,013
18,215
12,954
12,95418,21516,01318,80522,946283,589155,408000000
> Total Liabilities 
73,728
114,908
203,789
464,603
1,820,159
4,845,574
4,619,909
4,811,610
5,083,363
4,819,082
2,583,377
2,716,230
2,370,645
2,370,6452,716,2302,583,3774,819,0825,083,3634,811,6104,619,9094,845,5741,820,159464,603203,789114,90873,728
   > Total Current Liabilities 
73,728
81,274
186,789
446,245
1,439,260
4,002,338
3,520,158
3,273,297
4,017,634
4,765,945
2,540,500
2,678,329
2,336,310
2,336,3102,678,3292,540,5004,765,9454,017,6343,273,2973,520,1584,002,3381,439,260446,245186,78981,27473,728
       Short-term Debt 
0
0
0
0
0
0
1,750,000
2,110,901
1,653,429
0
0
0
0
00001,653,4292,110,9011,750,000000000
       Short Long Term Debt 
0
0
0
0
0
0
1,750,000
2,110,901
1,653,429
1,677,900
1,352,445
1,558,129
1,454,973
1,454,9731,558,1291,352,4451,677,9001,653,4292,110,9011,750,000000000
       Accounts payable 
12,665
37,617
35,305
49,962
76,891
187,352
124,628
183,623
316,149
302,029
284,363
270,487
75,481
75,481270,487284,363302,029316,149183,623124,628187,35276,89149,96235,30537,61712,665
       Other Current Liabilities 
61,063
43,657
141,484
396,283
582,369
2,058,244
1,524,431
395,157
518,265
801,301
279,591
322,554
11,343
11,343322,554279,591801,301518,265395,1571,524,4312,058,244582,369396,283141,48443,65761,063
   > Long-term Liabilities 
0
0
0
0
0
0
1,099,751
1,538,314
1,065,729
53,137
42,877
37,901
34,335
34,33537,90142,87753,1371,065,7291,538,3141,099,751000000
       Other Liabilities 
0
596
1,396
15,368
370,135
543,236
126,985
82,840
68,966
53,137
42,877
37,901
0
037,90142,87753,13768,96682,840126,985543,236370,13515,3681,3965960
       Deferred Long Term Liability 
0
0
0
0
0
70,761
60,972
124,954
120,850
52,017
29,187
17,210
0
017,21029,18752,017120,850124,95460,97270,76100000
> Total Stockholder Equity
2,120,742
2,168,091
2,332,861
2,391,120
3,021,221
3,403,113
3,963,091
4,173,917
4,324,011
1,521,364
1,846,228
1,894,213
1,631,238
1,631,2381,894,2131,846,2281,521,3644,324,0114,173,9173,963,0913,403,1133,021,2212,391,1202,332,8612,168,0912,120,742
   Common Stock
140,000
280,000
280,000
280,000
731,890
733,010
2,198,290
2,198,123
2,198,123
2,198,123
2,198,123
2,198,123
0
02,198,1232,198,1232,198,1232,198,1232,198,1232,198,290733,010731,890280,000280,000280,000140,000
   Retained Earnings 
297,153
327,367
477,213
520,518
1,019,000
1,610,640
1,411,279
1,611,078
1,704,000
-930,436
-530,387
-742,512
-1,033,841
-1,033,841-742,512-530,387-930,4361,704,0001,611,0781,411,2791,610,6401,019,000520,518477,213327,367297,153
   Capital Surplus 0000000000000
   Treasury Stock000000-1,395-4,32800000
   Other Stockholders Equity 
0
0
0
0
0
0
4,357
-7,228
2,262
-165,949
-266,709
-9,612
0
0-9,612-266,709-165,9492,262-7,2284,357000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,744,897
Cost of Revenue-597,028
Gross Profit2,147,8692,147,869
 
Operating Income (+$)
Gross Profit2,147,869
Operating Expense-2,564,112
Operating Income180,785-416,243
 
Operating Expense (+$)
Research Development87,429
Selling General Administrative1,886,543
Selling And Marketing Expenses-
Operating Expense2,564,1121,973,972
 
Net Interest Income (+$)
Interest Income22,003
Interest Expense-51,727
Other Finance Cost-25,425
Net Interest Income-55,148
 
Pretax Income (+$)
Operating Income180,785
Net Interest Income-55,148
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-77,279180,785
EBIT - interestExpense = -51,727
-97,810
-46,083
Interest Expense51,727
Earnings Before Interest and Taxes (EBIT)--25,552
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-77,279
Tax Provision-18,483
Net Income From Continuing Ops-95,762-95,762
Net Income-97,810
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-55,148
 

Technical Analysis of Gloria
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gloria. The general trend of Gloria is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gloria's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Harbin Gloria Pharmaceuticals.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.08 < 2.18 < 2.18.

The bearish price targets are: 1.91 > 1.67.

Tweet this
Harbin Gloria Pharmaceuticals Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Harbin Gloria Pharmaceuticals. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Harbin Gloria Pharmaceuticals Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Harbin Gloria Pharmaceuticals. The current macd is -0.02752341.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gloria price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Gloria. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Gloria price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Harbin Gloria Pharmaceuticals Daily Moving Average Convergence/Divergence (MACD) ChartHarbin Gloria Pharmaceuticals Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Harbin Gloria Pharmaceuticals. The current adx is 17.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Gloria shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Harbin Gloria Pharmaceuticals Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Harbin Gloria Pharmaceuticals. The current sar is 2.1617564.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Harbin Gloria Pharmaceuticals Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Harbin Gloria Pharmaceuticals. The current rsi is 51.37. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Harbin Gloria Pharmaceuticals Daily Relative Strength Index (RSI) ChartHarbin Gloria Pharmaceuticals Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Harbin Gloria Pharmaceuticals. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gloria price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Harbin Gloria Pharmaceuticals Daily Stochastic Oscillator ChartHarbin Gloria Pharmaceuticals Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Harbin Gloria Pharmaceuticals. The current cci is -6.90362907.

Harbin Gloria Pharmaceuticals Daily Commodity Channel Index (CCI) ChartHarbin Gloria Pharmaceuticals Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Harbin Gloria Pharmaceuticals. The current cmo is 10.84.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Harbin Gloria Pharmaceuticals Daily Chande Momentum Oscillator (CMO) ChartHarbin Gloria Pharmaceuticals Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Harbin Gloria Pharmaceuticals. The current willr is -37.93103448.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Gloria is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Harbin Gloria Pharmaceuticals Daily Williams %R ChartHarbin Gloria Pharmaceuticals Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Harbin Gloria Pharmaceuticals.

Harbin Gloria Pharmaceuticals Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Harbin Gloria Pharmaceuticals. The current atr is 0.06828971.

Harbin Gloria Pharmaceuticals Daily Average True Range (ATR) ChartHarbin Gloria Pharmaceuticals Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Harbin Gloria Pharmaceuticals. The current obv is 22,300,792.

Harbin Gloria Pharmaceuticals Daily On-Balance Volume (OBV) ChartHarbin Gloria Pharmaceuticals Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Harbin Gloria Pharmaceuticals. The current mfi is 58.72.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Harbin Gloria Pharmaceuticals Daily Money Flow Index (MFI) ChartHarbin Gloria Pharmaceuticals Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Harbin Gloria Pharmaceuticals.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Harbin Gloria Pharmaceuticals Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Harbin Gloria Pharmaceuticals based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.368
Ma 20Greater thanMa 502.076
Ma 50Greater thanMa 1002.092
Ma 100Greater thanMa 2002.255
OpenGreater thanClose2.050
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Gloria with someone you think should read this too:
  • Are you bullish or bearish on Gloria? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gloria? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Harbin Gloria Pharmaceuticals

I send you an email if I find something interesting about Harbin Gloria Pharmaceuticals.


Comments

How you think about this?

Leave a comment

Stay informed about Harbin Gloria Pharmaceuticals.

Receive notifications about Harbin Gloria Pharmaceuticals in your mailbox!